Chandigarh Herald

Hypertriglyceridemia Treatment Market and Market Insights Report 2030

 Breaking News
  • No posts were found

Hypertriglyceridemia Treatment Market and Market Insights Report 2030

November 11
19:56 2021
Hypertriglyceridemia Treatment Market and Market Insights Report 2030

The report covers the descriptive overview of hypertriglyceridemia (HTG) explaining its pathophysiology, disease classification, diagnostic approaches, and treatment. The report provides an understanding of the future competition in hypertriglyceridemia (HTG) by reviewing the market drivers and barriers.

 

Hypertriglyceridemia Overview

Hypertriglyceridemia refers to a fasting plasma triglyceride measurement that is increased, typically above the 95th percentile for age and sex along with additional quantitative or qualitative lipoprotein abnormalities. Patients can fluctuate between hypertriglyceridemic states: given appropriate metabolic stress, mild or moderate hypertriglyceridemia can deteriorate into severe hypertriglyceridemia.

 

Download Sample Report- Hypertriglyceridemia Market Report

 

Some of the key highlights of the Hypertriglyceridemia market report

  • About a third of participants had serum triglycerides above 150 mg/dL. In subjects aged 60 years or older, the prevalence was 42%, and 2% of subjects with hypertriglyceridemia had triglycerides of more than 500 mg/dL.
  • The incidence of hypertriglyceridemia also varies by race, with a higher incidence observed in Hispanic-Americans and Asian-Indians, and lower incidence in African-Americans who generally have lower triglyceride levels. In addition, severe hypertriglyceridemia is the third leading cause of pancreatitis in the United States.

 

Hypertriglyceridemia Market: Companies

  • AstraZeneca
  • Amarin Pharma Inc.
  • GlaxoSmithKline
  • And many others

 

Hypertriglyceridemia Market Outlook

Hypertriglyceridemia (HTG) is well known to be associated with severe diseases such as acute pancreatitis and cardiovascular disease. The treatment regimens include nutritional intervention, the use of anti-hyperlipidemic drugs, and therapeutic apheresis. Apheretic treatment is indicated in medical emergencies such as hypertriglyceridemic pancreatitis.

 

Hypertriglyceridemia Market: Treatment

The general treatment regimen for HTG includes dietary restrictions and lipid-lowering drug treatment such as the use of medium-chain triglycerides (MCT), fibrates, omega-3-fatty acids (omega-3-FA), and nicotinic acid. Yet, drugs of the first choice, such as fibrates, do not offer fast onset of action, while immediately acting drugs like omega-3-FA and MCT may not be powerful enough to lower excessively elevated TG levels rapidly.

 

Hypertriglyceridemia Emerging Drugs

The dynamics of the Hypertriglyceridemia (HTG) market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world and expected launch of emerging therapies during the forecast period.

 

Hypertriglyceridemia Market Drivers

  • Increase in research activities
  • Increasing disease prevalence
  • A surge in a number of clinical studies

 

Hypertriglyceridemia Market Barriers

  • Treatment costs
  • Need for novel therapeutics              
  • Need for targeted treatment regimen

 

Request Sample ReportHypertriglyceridemia Market Insights

 

Table of content

1. Key Insights

2. Executive Summary of Hypertriglyceridemia

3. Competitive Intelligence Analysis for Hypertriglyceridemia

4. Hypertriglyceridemia: Market Overview at a Glance

5. Hypertriglyceridemia: Disease Background and Overview

6. Patient Journey

7. Hypertriglyceridemia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Hypertriglyceridemia Treatment

11. Marketed Products

12. Emerging Therapies

13. Hypertriglyceridemia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Hypertriglyceridemia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

About DelveInsight

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

 

Contact Us

Yash

[email protected]

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles